# Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer

> **NCT00003400** · PHASE2 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 45 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** carmustine
- **DRUG:** cisplatin
- **DRUG:** melphalan
- **DRUG:** vinorelbine tartrate
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00003400
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09
- **Primary completion:** 2000-03
- **Final completion:** 2000-03
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2019-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003400, "Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00003400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*